Universal Vision Biotechnology Co Ltd Cash Flow Conversion Efficiency
Universal Vision Biotechnology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Universal Vision Biotechnology Co Ltd (3218) has a cash flow conversion efficiency ratio of 0.125x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$521.08 Million ≈ $16.42 Million USD) by net assets (NT$4.16 Billion ≈ $131.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Universal Vision Biotechnology Co Ltd (2003–2025)
Cash flow conversion efficiency of Universal Vision Biotechnology Co Ltd from 2003 to 2025. This chart illustrates how Universal Vision Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Universal Vision Biotechnology Co Ltd stock price for real-time trading data and today's change.
Universal Vision Biotechnology Co Ltd Cash Flow Conversion Ratio Explained
Universal Vision Biotechnology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Universal Vision Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universal Vision Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Universal Vision Biotechnology Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guggenheim Taxable Municipal Managed Duration Trust
NYSE:GBAB
|
0.033x |
|
KRAKacquisition Corp Class A Ordinary Shares
NASDAQ:KRAQ
|
-0.001x |
|
Sidetrade
PA:ALBFR
|
0.086x |
|
Ind-Swift Laboratories Limited
NSE:INDSWFTLAB
|
-0.015x |
|
SPCG Public Company Limited
BK:SPCG
|
0.013x |
|
Australian Ethical Investment Ltd
AU:AEF
|
0.373x |
|
Net Holding AS
IS:NTHOL
|
0.017x |
|
Hanwha Corp Preferred
KO:00088K
|
0.032x |
Annual Cash Flow Conversion Efficiency for Universal Vision Biotechnology Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Universal Vision Biotechnology Co Ltd from 2003 to 2025. Review 3218 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.16 Billion ≈ $131.04 Million |
NT$1.67 Billion ≈ $52.50 Million |
0.401x | -10.00% |
| 2024-12-31 | NT$3.76 Billion ≈ $118.33 Million |
NT$1.67 Billion ≈ $52.68 Million |
0.445x | -4.20% |
| 2023-12-31 | NT$3.34 Billion ≈ $105.32 Million |
NT$1.55 Billion ≈ $48.95 Million |
0.465x | +3.68% |
| 2022-12-31 | NT$2.83 Billion ≈ $89.14 Million |
NT$1.27 Billion ≈ $39.95 Million |
0.448x | +14.47% |
| 2021-12-31 | NT$2.33 Billion ≈ $73.36 Million |
NT$911.77 Million ≈ $28.73 Million |
0.392x | -3.44% |
| 2020-12-31 | NT$2.04 Billion ≈ $64.25 Million |
NT$827.08 Million ≈ $26.06 Million |
0.406x | +64.02% |
| 2019-12-31 | NT$1.70 Billion ≈ $53.41 Million |
NT$419.18 Million ≈ $13.21 Million |
0.247x | +45.68% |
| 2018-12-31 | NT$1.61 Billion ≈ $50.69 Million |
NT$273.07 Million ≈ $8.60 Million |
0.170x | +13.59% |
| 2017-12-31 | NT$1.58 Billion ≈ $49.86 Million |
NT$236.48 Million ≈ $7.45 Million |
0.149x | -32.07% |
| 2016-12-31 | NT$1.16 Billion ≈ $36.54 Million |
NT$255.13 Million ≈ $8.04 Million |
0.220x | +37.79% |
| 2015-12-31 | NT$1.15 Billion ≈ $36.22 Million |
NT$183.54 Million ≈ $5.78 Million |
0.160x | -17.91% |
| 2014-12-31 | NT$1.14 Billion ≈ $35.94 Million |
NT$221.81 Million ≈ $6.99 Million |
0.194x | +16.31% |
| 2013-12-31 | NT$1.10 Billion ≈ $34.61 Million |
NT$183.66 Million ≈ $5.79 Million |
0.167x | +144.36% |
| 2011-12-31 | NT$1.14 Billion ≈ $35.88 Million |
NT$77.91 Million ≈ $2.45 Million |
0.068x | -46.06% |
| 2010-12-31 | NT$663.76 Million ≈ $20.91 Million |
NT$84.19 Million ≈ $2.65 Million |
0.127x | -26.41% |
| 2008-12-31 | NT$539.22 Million ≈ $16.99 Million |
NT$92.94 Million ≈ $2.93 Million |
0.172x | -0.41% |
| 2006-12-31 | NT$546.91 Million ≈ $17.23 Million |
NT$94.66 Million ≈ $2.98 Million |
0.173x | -57.01% |
| 2004-12-31 | NT$305.87 Million ≈ $9.64 Million |
NT$123.14 Million ≈ $3.88 Million |
0.403x | +71.74% |
| 2003-12-31 | NT$235.39 Million ≈ $7.42 Million |
NT$55.18 Million ≈ $1.74 Million |
0.234x | -- |
About Universal Vision Biotechnology Co Ltd
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical instruments, eyeglasses, contact lenses, and eyeglass accessories. It is also involved in eyeglasses optometry and dispensing services and leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy analysis, as we… Read more